BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei H, Jiang H, Liu X, Qin Y, Zheng T, Liu S, Zhang X, Song B. Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma? Eur J Radiol 2020;132:109312. [PMID: 33022551 DOI: 10.1016/j.ejrad.2020.109312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Huo L, Zhang J, Feng Y, Liu Y, Wu Y, Jia N, Liu W. A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm). Front Oncol 2022;12:992301. [DOI: 10.3389/fonc.2022.992301] [Reference Citation Analysis]
2 Chen Y, Qin Y, Wu Y, Wei H, Wei Y, Zhang Z, Duan T, Jiang H, Song B. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging. Front Immunol 2022;13:973153. [DOI: 10.3389/fimmu.2022.973153] [Reference Citation Analysis]
3 Wang L, Ma X, Feng B, Wang S, Liang M, Li D, Wang S, Zhao X. Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm. Front Oncol 2022;12:899404. [PMID: 35756618 DOI: 10.3389/fonc.2022.899404] [Reference Citation Analysis]
4 Yang J, Jiang H, Xie K, Bashir MR, Wan H, Huang J, Qin Y, Chen J, Lu Q, Song B. Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: an intra-individual comparative study based on the Liver Imaging Reporting and Data System. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110397] [Reference Citation Analysis]
5 Wang Y, Zhu GQ, Zhou CW, Li N, Yang C, Zeng MS. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Eur Radiol 2022. [PMID: 35316365 DOI: 10.1007/s00330-022-08691-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang H, Han P, Huang M, Yue X, Wu L, Li X, Fan W, Li Q, Ma G, Lei P. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma. Abdom Radiol (NY) 2022;47:948-56. [PMID: 34962593 DOI: 10.1007/s00261-021-03392-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wu H, Wang Z, Liang Y, Tan C, Wei X, Zhang W, Yang R, Mo L, Jiang X. A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study. Front Oncol 2021;11:681489. [PMID: 35127463 DOI: 10.3389/fonc.2021.681489] [Reference Citation Analysis]
8 Wang X, Sun Y, Zhou X, Shen Z, Zhang H, Xing J, Zhou Y. Histogram peritumoral enhanced features on MRI arterial phase with extracellular contrast agent can improve prediction of microvascular invasion of hepatocellular carcinoma. Quant Imaging Med Surg 2022;12:1372-84. [PMID: 35111631 DOI: 10.21037/qims-21-499] [Reference Citation Analysis]
9 Cunha GM, Hosseini M, Furlan A, Fowler KJ. Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation. AJR Am J Roentgenol 2021;:1-10. [PMID: 34406054 DOI: 10.2214/AJR.21.26436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wu L, Bi J, Liu L, Zeng Y. Magnetic resonance elastography can predict the development of hepatocellular carcinoma: a meta-analysis and systematic review. J Gastrointest Oncol 2021;12:1215-22. [PMID: 34532081 DOI: 10.21037/jgo-21-196] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Chang SD, Cunha GM, Chernyak V. MR Imaging Contrast Agents: Role in Imaging of Chronic Liver Diseases. Magn Reson Imaging Clin N Am 2021;29:329-45. [PMID: 34243921 DOI: 10.1016/j.mric.2021.05.014] [Reference Citation Analysis]
12 Moura Cunha G, Chernyak V, Fowler KJ, Sirlin CB. Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:513-27. [PMID: 34104640 DOI: 10.2147/JHC.S268288] [Reference Citation Analysis]